Trial Profile
A post-marketing surveillance study of Neutrolin, a novel catheter lock solution, in hemodialysis patients with tunneled central venous catheters (CVC)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2017
Price :
$35
*
At a glance
- Drugs Citrate/heparin/taurolidine (Primary)
- Indications Catheter infections
- Focus Adverse reactions
- 06 Dec 2017 Results published in the European Journal of Clinical Microbiology and Infectious Diseases
- 06 Dec 2017 Status changed from recruiting to completed, according to results published in the European Journal of Clinical Microbiology and Infectious Diseases.
- 05 May 2016 According to a CorMedix media release, data (n=199) from this study were presented at the 1st Gulf Congress of Clinical Microbiology and Infectious Diseases.